The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia
Open accessAbstract
Treatment of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors has advanced to a stage where many patients achieve very low or undetectable levels of disease. Remarkably, some of these patients remain in sustained remission when treatment is withdrawn, suggesting that they may be at least operationally cured of their disease. Accurate definition of deep molecular responses (MRs) is therefore increasingly important for optimal patient management and comparison of independent data sets. We previously published proposals for broad standardized definitions of MR at different levels of sensitivity. Here we present detailed laboratory recommendations, developed as part of the European Treatment and Outcome Study for CML (EUTOS), to enable testing laboratories to score MR in a reproducible manner for CML patients expressing the most common BCR-ABL1 variants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Baccarani, M., Deininger, M. W., Rosti, G., Hochhaus, A., Soverini, S., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Guilhot, F., et al. (2013) · Blood · doi:10.1182/blood-2013-05-501569 · Cited by 1,987
Self-citationNilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
Saglio, G., Kim, D.-W., Issaragrisil, S., le Coutre, P., Etienne, G., Lobo, C., Pasquini, R., Clark, R. E., Hochhaus, A., Hughes, T. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912614 · Cited by 1,678
Self-citationDasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Kantarjian, H., Shah, N. P., Hochhaus, A., Cortes, J., Shah, S., Ayala, M., Moiraghi, B., Shen, Z., Mayer, J., Pasquini, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002315 · Cited by 1,589
Self-citationMahon, F.-X., Réa, D., Guilhot, J., Guilhot, F., Huguet, F., Nicolini, F., Legros, L., Charbonnier, A., Guerci, A., Varet, B., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70233-3 · Cited by 1,550
Gabert, J., Beillard, E., van der Velden, V. H. J., Bi, W., Grimwade, D., Pallisgaard, N., Barbany, G., Cazzaniga, G., Cayuela, J. M., Cavé, H., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403135 · Cited by 1,284
Self-citationHughes, T. (2006) · Blood · doi:10.1182/blood-2006-01-0092 · Cited by 1,199
Beillard, E., Pallisgaard, N., van der Velden, V. H. J., Bi, W., Dee, R., van der Schoot, E., Delabesse, E., Macintyre, E., Gottardi, E., Saglio, G., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403136 · Cited by 881
Self-citationBose, S., Deininger, M., Gora-Tybor, J., Goldman, J. M., & Melo, J. V. (1998) · Blood · doi:10.1182/blood.v92.9.3362 · Cited by 463
Rousselot, P., Charbonnier, A., Cony-Makhoul, P., Agape, P., Nicolini, F. E., Varet, B., Gardembas, M., Etienne, G., Réa, D., Roy, L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5797 · Cited by 416
Branford, S., Fletcher, L., Cross, N. C. P., Müller, M. C., Hochhaus, A., Kim, D.-W., Radich, J. P., Saglio, G., Pane, F., Kamel-Reid, S., et al. (2008) · Blood · doi:10.1182/blood-2008-04-150680 · Cited by 388
Self-citationStandardized definitions of molecular response in chronic myeloid leukemia
Cross, N. C. P., White, H. E., Müller, M. C., Saglio, G., & Hochhaus, A. (2012) · Leukemia · doi:10.1038/leu.2012.104 · Cited by 378
Self-citationRoss, D. M., Branford, S., Seymour, J. F., Schwarer, A. P., Arthur, C., Bartley, P. A., Slader, C., Field, C., Dang, P., Filshie, R. J., et al. (2010) · Leukemia · doi:10.1038/leu.2010.185 · Cited by 268
Branford, S., Cross, N. C. P., Hochhaus, A., Radich, J., Saglio, G., Kaeda, J., Goldman, J., & Hughes, T. (2006) · Leukemia · doi:10.1038/sj.leu.2404388 · Cited by 196
Self-citationMorley, A. A. (2014) · Biomolecular Detection and Quantification · doi:10.1016/j.bdq.2014.06.001 · Cited by 172
White, H. E., Matejtschuk, P., Rigsby, P., Gabert, J., Lin, F., Lynn Wang, Y., Branford, S., Müller, M. C., Beaufils, N., Beillard, E., et al. (2010) · Blood · doi:10.1182/blood-2010-06-291641 · Cited by 159
Self-citationDetection and Quantification of BCR-ABL1 Fusion Transcripts by Droplet Digital PCR
Jennings, L. J., George, D., Czech, J., Yu, M., & Joseph, L. J. (2014) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.10.007 · Cited by 122
Goh, H., Lin, M., Fukushima, T., Saglio, G. N., Kim, D., Choi, S.-Y., Kim, S., Lee, J. E., Lee, Y., Oh, S.-M., et al. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.555569 · Cited by 110
Self-citationGuidelines for the measurement of BCR‐ABL1 transcripts in chronic myeloid leukaemia
Foroni, L., Wilson, G. A., Gerrard, G., Mason, J., Grimwade, D. J., White, H., de Castro, D. G., Austin, S. J., Awan, A., Burt, E. C., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08603.x · Cited by 105
Self-citationStandardisation of molecular monitoring for chronic myeloid leukaemia
Cross, N. C. P. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.04.001 · Cited by 96
Self-citationSobrinho-Simões, M. A., Wilczek, V. J., Score, J., Cross, N. C. P., Apperley, J. F., & Melo, J. V. (2010) · Blood · doi:10.1182/blood-2009-11-255109 · Cited by 83
Self-citationChronic Myelogenous Leukemia, Version 1.2014
O'Brien, S. M., Radich, J. P., Abboud, C. N., Akhtari, M., Altman, J. K., Berman, E., DeAngelo, D. J., Deininger, M. W., Devine, S. M., Fathi, A. T., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0157 · Cited by 83
White, H., Deprez, L., Corbisier, P., Hall, V., Lin, F., Mazoua, S., Trapmann, S., Aggerholm, A., Andrikovics, H., Akiki, S. J., et al. (2014) · Leukemia · doi:10.1038/leu.2014.217 · Cited by 79
Self-citationChronic Myelogenous Leukemia, Version 1.2015
O’Brien, S., Radich, J. P., Abboud, C. N., Akhtari, M., Altman, J. K., Berman, E., Curtin, P. T., DeAngelo, D. J., Deininger, M. W., Devine, S. M., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0159 · Cited by 76
Hromadníková, I., Houbová, B., Hridelova, D., et al. (2003) · Prenatal Diagnosis · doi:10.1002/pd.556 · Cited by 68
Diagnosis and Monitoring of Chronic Myeloid Leukemia by Qualitative and Quantitative RT-PCR
Branford, S., & Hughes, T. P. (2006) · Humana Press eBooks · doi:10.1385/1-59745-017-0:69 · Cited by 56
White, H., Hedges, J. B., Bendit, I., Branford, S., Colomer, D., Hochhaus, A., Hughes, T. P., Kamel‐Reid, S., Kim, D., Modur, V. R., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.196477 · Cited by 49
Self-citationJennings, L. J., Smith, F. A., Halling, K. C., Persons, D. L., Kamel‐Reid, S., & _, _. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0136-oa · Cited by 24
The European LeukemiaNet: achievements and perspectives
Hehlmann, R., Grimwade, D. J., Simonsson, B., Apperley, J., Baccarani, M., Barbui, T., Barosi, G., Bassan, R., Béné, M. C., Berger, U., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.032979 · Cited by 16
Self-citationMauté, C., Nibourel, O., Réa, D., Coiteux, V., Grardel, N., Preudhomme, C., & Cayuela, J. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.05.067 · Cited by 8
Cited by
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0776-2 · Cited by 1,547
Self-citationSaussele, S., Richter, J., Guilhot, J., Gruber, F. X., Hjorth-Hansen, H., Almeida, A., Janssen, J. J. W. M., Mayer, J., Koskenvesa, P., Panayiotidis, P., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30192-x · Cited by 618
Self-citationCortes, J. E., Gambacorti-Passerini, C., Deininger, M. W., Mauro, M. J., Chuah, C., Kim, D.-W., Dyagil, I., Glushko, N., Milojkovic, D., le Coutre, P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.7162 · Cited by 495
Self-citationChronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hochhaus, A., Saussele, S., Rosti, G., Mahon, F.-X., Janssen, J. J. W. M., Hjorth-Hansen, H., Richter, J., & Buske, C. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx219 · Cited by 343
Self-citationMoving treatment-free remission into mainstream clinical practice in CML
Hughes, T. P., & Ross, D. M. (2016) · Blood · doi:10.1182/blood-2016-01-694265 · Cited by 317
Metadata
- Authors
- Cross, N. C. P., White, H. E., Colomer, D., Ehrencrona, H., Foroni, L., Gottardi, E., Lange, T., Lion, T., Machova Polakova, K., Dulucq, S., Martinelli, G., Oppliger Leibundgut, E., Pallisgaard, N., Barbany, G., Sacha, T., Talmaci, R., Izzo, B., Saglio, G., Pane, F., Müller, M. C., & Hochhaus, A.
- Venue
- Leukemia
- Published
- 2015-02-05
- Volume
- 29
- Issue
- 5
- Pages
- 999-1003
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2077812841
- Cited by
- 336
- References
- 30
- FWCI
- 28.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.